Dr. Shirani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Nebraska Medical Center
988440 Nebraska Medical Center
Omaha, NE 68198
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Neuroimmunology & Multiple Sclerosis, 2017 - 2019
Washington University in St. LouisMaster of Science in Clinical Investigation, 2017 - 2019
University of Texas Southwestern Medical CenterResidency, Neurology, 2013 - 2017- University of Texas Southwestern Medical CenterInternship, Preliminary Year, 2013 - 2014
- University of British ColumbiaPost-Doctoral Fellowship, 2009 - 2013
Tehran University of Medical Sciences School of MedicineClass of 2005, MD
Certifications & Licensure
DC State Medical License 2024 - 2027
CA State Medical License 2024 - 2026
GA State Medical License 2024 - 2026
IL State Medical License 2024 - 2026
MO State Medical License Active through 2026
NE State Medical License Active through 2026
CO State Medical License 2024 - 2025- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Physicians Scientist Program Award University of Nebraska Medical Center, 2019-2021
- Clinician Scientist Development Award National Multiple Sclerosis Society (USA), 2017-2020
- Clinical Research Training Scholarship American Academy of Neurology, 2017-2019
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsDifferential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Aus...Lilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, Olga Ciccarelli, Daniel Ontaneda
The Lancet. Neurology. 2024-10-01 - 2 citationsRole of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion.Afsaneh Shirani, Olaf Stuve, Anne H Cross
Neurologic Clinics. 2024-02-01 - 4 citationsExploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.Afsaneh Shirani, Anne H Cross, Olaf Stuve
Therapeutic Advances in Neurological Disorders. 2024-01-01
Press Mentions
New Faculty Spotlight: Afsaneh Shirani, M.D.July 22nd, 2019
Diabetes Weight Loss Drugs Could Be Linked to Reduced Risk of MS, Study FindsApril 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
